WANG Feng-xiu, ZHANG Ting-ming, DING Chang-ling. Qingfei Huazhuo Treating 50 Chronic Obstructive Pulmonary Disease Patients During Acute Exacerbation Period[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(3): 187-190.
DOI:
WANG Feng-xiu, ZHANG Ting-ming, DING Chang-ling. Qingfei Huazhuo Treating 50 Chronic Obstructive Pulmonary Disease Patients During Acute Exacerbation Period[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(3): 187-190. DOI: 10.13422/j.cnki.syfjx.2015030187.
Qingfei Huazhuo Treating 50 Chronic Obstructive Pulmonary Disease Patients During Acute Exacerbation Period
Objective: To discuss the curative efficacy of Qingfei Huazhuo decoction in assisted-treating acute exacerbation of chronic obstructive pulmonary disease (AECOPD) of phlegm heat obstructing lung syndrome and to investigate its influence on serum superoxide dismutase (SOD)
malondialdehyde (MDA) and interleukin-10 (IL-10) and tumor necrosis factor-α (TNF-α). Method: One hundred AECOPD patients were randomly divided into the control group (50 cases) and the traditional Chinese medicine group (50 cases) by random number table. Patients in the control group received comprehensive treatment therapy including controlling oxygen therapy
infection resistance
hormone and bronchial relaxation. Based on the treatment of control group
patients in traditional Chinese medicine group added Qingfei Huazhuo decoction
1 does daily. All patients received 2-week treatment. Scores of the main symptoms including cough up phlegm
cough
asthma and pulmonary rales were recorded before and after treatment. Quality of life through respiratory function state and difficulty in breathing questionnaire-modified (PFSDQ-M) were evaluated. The pulmonary function was appraised before and after treatment. Levels of serum SOD
MDA
IL-10 and TNF-α were tested before and after therapy. Result: The clinical effect in traditional Chinese medicine group was superior to that in control group with statistically significant difference (P<0.05). After treatment
scores of cough up phlegm
cough
asthma and pulmonary rales in traditional Chinese medicine group were less than those in control group (P<0.01). Quality of life score in traditional Chinese medicine group was inferior to that in control group (P<0.01). Forced expiratory volume in one second(FEV1) and forced expiratory volume accounted for forced vital capacity(FEV1/FVC) in control group improved
but there was no statistically significant difference. Expected value of FEV1 and FEV1/FVC in control group rose as compared with that before therapy
while the rose degree was higher than that in control group (P<0.01). Levels of serum TNF-α and MDA in traditional Chinese medicine group were lower than those in control group (P<0.01). Besides
the IL-10 and SOD levels were higher than those in control group (P<0.01). Conclusion: Qingfei Huazhuo decoction could reduce clinical symptoms of AECOPD of phlegm heat obstructing lung syndrome
improve lung function and patient's life of quality. The mechanism of action may be related to adjusting oxidation/antioxidant system and inhibiting inflammatory reaction.
Effect of Modified Erchentang on GATA3 and T-bet mRNA Expressions in Lung Tissue of Chronic Obstructive Pulmonary Disease Rats
Efficacy of Da Chengqitang, Da Chaihutang Quadruple Therapy of Syndrome Differentiation in Treatment of Early Acute Pancreatitis with Gastrointestinal Heat and Liver and Gallbladder Damp-heat Syndrome and Its Effect on Serum Inflammatory Factors
Effect of Xuanfei Pingchuan Capsules on Rat COPD Model
Clinical Observation of Dizhuo Huatan Decoction on AECOPD with Syndrome of Phlegm and Blood Stasis Obstructing Lung
Effects of Qinda Decoction on Plasma Fibrinogen and Serum Inflammatory Cytokines and Plasma Fibrinogen of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Related Author
Yong-sheng BAO
Wen-ying XIE
Jun-yue WANG
Li-zhi SHANG
Ke WU
Liang LI
Xiao-yan WANG
Xiao-hui CHEN
Related Institution
Henan University of Chinese Medicine
Key Laboratory of State Administration of Traditional Chinese Medicine (Cardio-Cerebral Vessel Collateral Disease)
State Key Laboratory for Innovation and Transformation of Luobing Theory
Graduate School, Hebei Medical University
First Affiliated Hospital, Heilongjiang University of Chinese Medicine